Japan Hospice Holdings Inc. (JP:7061)

:7061

7061

Japan Hospice Holdings Inc.

RESEARCH TOOLSreports

Japan Hospice Holdings Inc. (7061) Price & Analysis

0 Followers

7061 Stock Chart & Stats

¥1120.00

¥7.00(0.51%)

At close: Jan 08 4:00 PM EST

¥1120.00

¥7.00(0.51%)

Day’s Range― - ―

52-Week Range¥715.00 - ¥1,653.00

Previous CloseN/A

Volume53.20K

Average Volume (3M)47.89K

Market Cap

¥6.66B

Enterprise Value¥17.72B

Total Cash (Recent Filing)¥1.40B

Total Debt (Recent Filing)¥12.70B

Price to Earnings (P/E)33.9

Beta1.15

Next Earnings

May 15, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.41%

Share Statistics

EPS (TTM)-3.16

Shares Outstanding8,428,100

10 Day Avg. Volume91,680

30 Day Avg. Volume47,890

Financial Highlights & Ratios

PEG Ratio-0.59

Price to Book (P/B)2.56

Price to Sales (P/S)0.66

P/FCF Ratio-7.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)199.5

Revenue Forecast (FY)¥20.00B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained top-line expansion over multiple years indicates durable demand and successful service penetration. For a hospice operator, consistent revenue growth reflects recurring patient flows, scalable facility and home-visit operations, and an ability to expand footprint within a structurally growing end‑of‑life care market.

Positive Operating Cash FlowImproved operating cash flow demonstrates the business can convert billing and reimbursements into cash, supporting day‑to‑day operations and interest servicing. Over 2–6 months this provides resilience versus purely accounting profits and is a necessary foundation for stabilizing the balance sheet.

Reimbursed, Insurance‑backed Revenue ModelRevenue tied to national healthcare and long‑term care insurance creates predictable pricing and durable demand, reducing commercial volatility. Structural public reimbursement supports steady utilization as Japan ages, enabling longer planning horizons and more predictable cash flows than purely private-pay models.

Bears Say

High Financial LeverageElevated leverage materially constrains strategic flexibility and increases refinancing and interest-rate risk. With heavy debt relative to equity, the company may struggle to fund expansions or absorb shocks without external financing, and higher interest costs will pressure margins and cash available for deleveraging.

Persistent Negative Free Cash FlowOngoing negative free cash flow implies internal funding is insufficient for capex and debt reduction, forcing reliance on external capital. This erodes liquidity cushions and raises structural funding risk: if capital markets tighten, the company may need to curtail investment or restructure financing.

Margin Compression And Weak ProfitabilitySignificant margin decline reduces the firm's ability to absorb cost increases and finance growth from earnings. Lower gross and net margins weaken returns on invested capital and prolong the timeline to rebuild equity, making long‑term capital allocation and debt reduction more difficult.

7061 FAQ

What was Japan Hospice Holdings Inc.’s price range in the past 12 months?

Japan Hospice Holdings Inc. lowest stock price was ¥715.00 and its highest was ¥1653.00 in the past 12 months.

What is Japan Hospice Holdings Inc.’s market cap?

Japan Hospice Holdings Inc.’s market cap is ¥6.66B.

When is Japan Hospice Holdings Inc.’s upcoming earnings report date?

Japan Hospice Holdings Inc.’s upcoming earnings report date is May 15, 2026 which is in 36 days.

How were Japan Hospice Holdings Inc.’s earnings last quarter?

Japan Hospice Holdings Inc. released its earnings results on Feb 13, 2026. The company reported -¥3.16 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.16.

Is Japan Hospice Holdings Inc. overvalued?

According to Wall Street analysts Japan Hospice Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Japan Hospice Holdings Inc. pay dividends?

Japan Hospice Holdings Inc. pays a Annually dividend of ¥25 which represents an annual dividend yield of 1.41%. See more information on Japan Hospice Holdings Inc. dividends here

What is Japan Hospice Holdings Inc.’s EPS estimate?

Japan Hospice Holdings Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Japan Hospice Holdings Inc. have?

Japan Hospice Holdings Inc. has 8,428,100 shares outstanding.

What happened to Japan Hospice Holdings Inc.’s price movement after its last earnings report?

Japan Hospice Holdings Inc. reported an EPS of -¥3.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.791%.

Which hedge fund is a major shareholder of Japan Hospice Holdings Inc.?

Currently, no hedge funds are holding shares in JP:7061

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Japan Hospice Holdings Inc.

Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also provides home care services, which supports medical care, including physical care and life support, as well as offers day and nursing multi-function home care services. The company was founded in 2017 and is headquartered in Tokyo, Japan.